novo nordisk nvo news

Novo Nordisk upgraded to Buy from Neutral at UBS

Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone'

Key Takeaways Novo Nordisk shares rose Wednesday on the company's home market in Denmark and in the U.S. after UBS analysts upgraded the stock.The analysts upgraded the Ozempic obesity drugmaker to a "buy,

Business Insider · 1d

Novo Nordisk upgraded to Buy from Neutral at UBS, as CagriSema selloff overdone

UBS analyst upgraded Novo Nordisk (NVO) to Buy from Neutral with a price target of DKK 750, down from DKK 1,100. Novo Nordisk is “well placed”

Fintel on MSN · 15h

UBS Upgrades Novo Nordisk A (NVO)

Fintel reports that on January 8, 2025, UBS upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Sell to Buy. Analyst Price Forecast Suggests 61.15% Upside As of December 23, 2024, the average one-year price target for Novo Nordisk A is $137.

Novo Nordisk Expands AI Partnership With Valo Health

Seeking Alpha on MSN · 1d

Novo Nordisk, Valo Health expand drug discovery deal

Novo Nordisk (NVO) and Valo Health expand collaboration to develop new treatments targeting cardiometabolic diseases. Read more here.

Business Insider · 1d

Novo Nordisk Expands Drug Discovery Collaboration With Valo Health For Cardiometabolic Diseases

Under the expanded collaboration, Valo's Opal Computational Platform will be integrated with Novo Nordisk's expertise in cardiometabolic diseases, deriving insights from real-world patient data, conducting trials, and developing therapeutics with human-centric AI small molecule design.

U.S. News & World Report · 1d

Novo Nordisk Expands AI Partnership With Valo Health for Development of Obesity Drugs

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and artificial intelligence (AI).

23hon MSN

Does Novo Nordisk A/S (NVO) Have an Attractive Valuation?

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth ...

bovnews1h

Bernstein Issues Mkt Perform Rating for Novo Nordisk A/S (NVO) Stock

Novo Nordisk A/S (NVO) stock saw a modest uptick, ending the day at $85.64 which represents a slight increase of $2.30 or 2.76% from the prior close of $83.34. The stock opened at $85.51 and touched a ...

1hon MSN

Novo, Eli Lilly to dominate global pharma sales in 2025: report

Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

24/7 Wall St20h

Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

First Hawaiian Bank Raises Stock Position in Novo Nordisk A/S (NYSE:NVO)

First Hawaiian Bank boosted its position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 30.3% in the fourth ...

Novo Nordisk Seeks to Strengthen Obesity Pipeline With Two Back-To-Back Biobuck Deals

Novo Nordisk expands collaboration with Valo Health for cardiometabolic drugs and partners with Variant Bio on metabolic ...

Historical Trends Warrant a Closer Look at Novo Nordisk (NVO) Call Options

Pharmaceutical stalwart Novo Nordisk (NVO) can’t seem to get anything good going these days. As TipRanks’ Vince Condarcuri ...

International Assets Investment Management LLC Cuts Position in Novo Nordisk A/S (NYSE:NVO)

International Assets Investment Management LLC reduced its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 98 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results